Detalles de la búsqueda
1.
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.
Haematologica
; 104(11): 2241-2248, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31666344
2.
Diagnostic value of whole-body ultra-low dose computed tomography in comparison with spinal magnetic resonance imaging in the assessment of disease in multiple myeloma.
Br J Haematol
; 177(3): 395-403, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28233900
3.
Response-adjusted ISS (RaISS) is a simple and reliable prognostic scoring system for predicting progression-free survival in transplanted patients with multiple myeloma.
Am J Hematol
; 87(2): 150-4, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22189759
4.
A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients.
Haematologica
; 100(12): e501-4, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26294723
5.
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.
Haematologica
; 95(4): 644-50, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19850903
6.
Role of a pre-existing neuropathy on the course of bortezomib-induced peripheral neurotoxicity.
J Peripher Nerv Syst
; 13(4): 267-74, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19192066
7.
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial.
Lancet
; 367(9513): 825-31, 2006 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-16530576
8.
Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: case-control study in patients with multiple myeloma and review of the literature.
Leuk Res
; 31(11): 1487-93, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17320951
9.
Implemented myeloma management with whole-body low-dose CT scan: a real life experience.
Leuk Lymphoma
; 57(7): 1539-45, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26788613
10.
Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
Clin Lymphoma Myeloma Leuk
; 15(4): 208-13, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25468321
11.
Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM).
Eur J Radiol
; 82(12): 2322-7, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24074647
12.
Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy.
Leuk Lymphoma
; 54(1): 62-8, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22784364
13.
High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study.
Leuk Lymphoma
; 52(5): 823-32, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21338283
14.
Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients.
J Clin Oncol
; 28(5): 800-7, 2010 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-20048187
15.
Efficacy and safety of bortezomib in patients with plasma cell leukemia.
Cancer
; 109(11): 2285-90, 2007 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17469169
16.
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia.
Support Care Cancer
; 13(6): 387-92, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15599778
17.
Growth Factors: Thrombopoietic Property of the Pineal Hormone Melatonin.
Hematology
; 4(4): 335-343, 1999.
Artículo
en Inglés
| MEDLINE | ID: mdl-11399574
18.
Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.
Cancer
; 100(2): 350-5, 2004 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14716771
19.
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial.
Blood
; 104(10): 3052-7, 2004 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15265788
Resultados
1 -
19
de 19
1
Próxima >
>>